Call Options

24 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$20.2 - $38.11 $6.48 Million - $12.2 Million
320,700 Added 340.08%
415,000 $12.7 Million
Q3 2024

Nov 14, 2024

SELL
$22.3 - $36.29 $1.61 Million - $2.62 Million
-72,200 Reduced 43.36%
94,300 $2.16 Million
Q2 2024

Aug 15, 2024

SELL
$16.07 - $31.84 $2.56 Million - $5.07 Million
-159,100 Reduced 48.86%
166,500 $4.81 Million
Q1 2024

May 07, 2024

BUY
$17.13 - $26.91 $2.83 Million - $4.45 Million
165,200 Added 102.99%
325,600 $6.72 Million
Q4 2023

Feb 14, 2024

SELL
$21.58 - $29.5 $1.3 Million - $1.78 Million
-60,400 Reduced 27.36%
160,400 $4.34 Million
Q3 2023

Nov 14, 2023

SELL
$25.8 - $39.97 $1.3 Million - $2.01 Million
-50,300 Reduced 18.55%
220,800 $6.54 Million
Q2 2023

Aug 11, 2023

SELL
$20.94 - $38.01 $1.18 Million - $2.14 Million
-56,400 Reduced 17.22%
271,100 $9.71 Million
Q1 2023

May 16, 2023

SELL
$22.92 - $33.76 $302,544 - $445,632
-13,200 Reduced 3.87%
327,500 $7.68 Million
Q4 2022

Feb 14, 2023

SELL
$25.44 - $59.78 $503,712 - $1.18 Million
-19,800 Reduced 5.49%
340,700 $9.27 Million
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $3.48 Million - $4.87 Million
79,800 Added 28.43%
360,500 $19.4 Million
Q2 2022

Aug 15, 2022

BUY
$28.82 - $77.35 $7.23 Million - $19.4 Million
250,800 Added 838.8%
280,700 $11.3 Million
Q1 2022

May 16, 2022

SELL
$48.25 - $100.49 $5.23 Million - $10.9 Million
-108,400 Reduced 78.38%
29,900 $1.98 Million
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $337,098 - $457,634
3,800 Added 2.83%
138,300 $13.8 Million
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $2.49 Million - $3.33 Million
-25,200 Reduced 15.78%
134,500 $16.8 Million
Q2 2021

Aug 11, 2021

SELL
$109.77 - $165.68 $3.23 Million - $4.87 Million
-29,400 Reduced 15.55%
159,700 $19.8 Million
Q1 2021

May 17, 2021

SELL
$127.04 - $179.1 $304,896 - $429,840
-2,400 Reduced 1.25%
189,100 $28.9 Million
Q4 2020

Feb 16, 2021

SELL
$99.96 - $135.93 $709,716 - $965,103
-7,100 Reduced 3.58%
191,500 $24.7 Million
Q3 2020

Nov 16, 2020

BUY
$80.32 - $111.8 $6.31 Million - $8.79 Million
78,600 Added 65.5%
198,600 $22.2 Million
Q2 2020

Aug 14, 2020

SELL
$60.49 - $97.5 $5.75 Million - $9.26 Million
-95,000 Reduced 44.19%
120,000 $9.74 Million
Q1 2020

May 15, 2020

BUY
$59.04 - $88.81 $6.89 Million - $10.4 Million
116,700 Added 118.72%
215,000 $15 Million
Q4 2019

Feb 14, 2020

SELL
$59.49 - $82.78 $4.99 Million - $6.94 Million
-83,800 Reduced 46.02%
98,300 $7.68 Million
Q3 2019

Nov 14, 2019

BUY
$62.59 - $110.3 $2.9 Million - $5.12 Million
46,400 Added 34.19%
182,100 $11.6 Million
Q2 2019

Aug 14, 2019

BUY
$63.94 - $91.11 $3.86 Million - $5.5 Million
60,400 Added 80.21%
135,700 $11.7 Million
Q1 2019

May 15, 2019

BUY
$34.3 - $97.98 $2.58 Million - $7.38 Million
75,300 New
75,300 $5.78 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.92B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.